Ivermectin is processed by the same liver enzyme that handles roughly half of all prescription drugs, which means it can interact with a surprisingly wide range of medications. The most clinically significant interactions involve blood thinners, certain sedatives, and immunosuppressant drugs. Understanding these interactions matters whether you’re taking ivermectin for a parasitic infection or any other prescribed use.
Why Ivermectin Interacts With So Many Drugs
Ivermectin is broken down in the liver primarily by an enzyme called CYP3A4. This single enzyme is responsible for metabolizing about 50% of all drugs in clinical use. When two medications compete for the same enzyme, one or both can build up to higher-than-expected levels in your bloodstream. The result is a stronger, longer-lasting effect that can tip into toxicity.
Beyond the liver enzyme issue, ivermectin is normally kept out of the brain by a transport protein that acts like a gatekeeper. Certain drugs or high doses of ivermectin itself can overwhelm this gatekeeper, allowing the drug to accumulate in the brain and affect nerve signaling. This is the mechanism behind the most serious interactions.
Blood Thinners, Especially Warfarin
The interaction between ivermectin and warfarin is one of the best-documented and most dangerous. Ivermectin interferes with the same clotting factors that warfarin targets (factors II, VII, IX, and X), creating an additive blood-thinning effect. The FDA specifically flags blood thinners as a known interaction risk.
In a published case report from Hospital Pharmacy, a patient on a stable warfarin dose saw his INR (a measure of how thin the blood is) jump from 3.1 to 4.2 within one week of taking ivermectin. An INR that high significantly increases the risk of dangerous bleeding. After holding two warfarin doses, his level dropped back to 2.7. If you take warfarin or a similar anticoagulant, your doctor will likely need to monitor your blood clotting more frequently if ivermectin is prescribed.
Sedatives and Anti-Seizure Medications
Ivermectin can enhance the activity of GABA receptors in the brain. GABA is the nervous system’s primary “calm down” signal, and many common sedatives work by boosting that same signal. When ivermectin reaches the brain in significant amounts and combines with another GABA-boosting drug, the sedative effects can stack in dangerous ways.
The drugs of concern in this category include:
- Benzodiazepines (such as diazepam, lorazepam, and alprazolam), commonly prescribed for anxiety and sleep
- Barbiturates, used for seizure disorders and occasionally for sedation
- Valproic acid, a widely used anti-epileptic medication
Combining ivermectin with any of these can increase the risk of excessive sedation, confusion, difficulty walking, and in severe cases, loss of consciousness. The risk is higher at elevated ivermectin doses, because higher doses are more likely to overwhelm the transport protein that normally keeps the drug out of the brain.
Immunosuppressant Drugs
Tacrolimus and sirolimus, commonly prescribed after organ transplants, are broken down by the same CYP3A4 enzyme as ivermectin. When both drugs compete for this enzyme, neither gets cleared efficiently. The result can be elevated blood levels of the immunosuppressant, the ivermectin, or both.
For transplant patients, even small changes in immunosuppressant levels can have serious consequences. Too much can suppress the immune system dangerously; too little risks organ rejection. If you take either of these medications and need ivermectin, your medical team will likely monitor your drug levels closely and may adjust dosing.
Hydrochlorothiazide (a Common Blood Pressure Drug)
Hydrochlorothiazide, one of the most widely prescribed diuretics for high blood pressure, showed strong inhibition of CYP3A4 in laboratory testing. Its inhibitory effect on this enzyme was roughly three times more potent than ivermectin’s own effect, with a significantly lower threshold for blocking enzyme activity. This suggests hydrochlorothiazide could meaningfully slow the breakdown of ivermectin in the liver, allowing it to accumulate.
Metformin, by contrast, showed only weak inhibition of CYP3A4 in the same research, indicating minimal risk of interfering with ivermectin metabolism. So if you take metformin for diabetes, it’s generally less of a concern than hydrochlorothiazide.
Other CYP3A4 Competitors
Because CYP3A4 processes so many medications, other drugs that strongly inhibit or compete for this enzyme can potentially raise ivermectin levels. Common categories include certain antifungal medications (like ketoconazole and itraconazole), some antibiotics (particularly erythromycin and clarithromycin), and HIV protease inhibitors. These drugs are well-known CYP3A4 inhibitors across many drug interactions, not just with ivermectin. If you take any of these, your prescriber should evaluate the interaction risk before adding ivermectin.
Alcohol and Ivermectin
Despite common concerns, research suggests alcohol does not meaningfully increase ivermectin blood levels. A study published in Acta Tropica found that co-administration of alcoholic beverages did not raise ivermectin plasma levels above those seen in fasting individuals. The researchers concluded that severe clinical reactions to ivermectin are not associated with alcohol intake. Earlier suspicions arose because some patients who experienced serious reactions during treatment for a tropical parasitic infection had been drinking, but the primary risk factor turned out to be the parasite load itself rather than the alcohol.
Warning Signs of a Dangerous Interaction
If ivermectin builds up to toxic levels because of a drug interaction, the symptoms are primarily neurological. Early signs include dizziness, excessive drowsiness, confusion, and difficulty with balance. More serious symptoms include tremors, inability to walk, muscle weakness, and seizures. In the most severe cases, people have experienced loss of consciousness, encephalopathy (a broad term for brain dysfunction), and coma.
Other symptoms that can accompany toxicity include nausea, vomiting, low blood pressure, rapid heart rate, and vision changes. These symptoms can develop within days of starting the interacting combination. If you notice unusual drowsiness, confusion, or balance problems after starting ivermectin alongside another medication, that warrants immediate medical attention.
The risk of a serious interaction increases with higher ivermectin doses and with medications that block either the CYP3A4 enzyme or the transport protein that keeps ivermectin out of the brain. Providing your pharmacist or prescriber with a complete list of your current medications is the most practical step you can take to avoid these interactions.